The largest database of trusted experimental protocols

Pcdna sirt1

Manufactured by GenePharma
Sourced in China

PcDNA-SIRT1 is a plasmid vector that contains the coding sequence for the SIRT1 gene. SIRT1 is a protein that plays a role in cellular processes such as gene expression, metabolism, and longevity. The PcDNA-SIRT1 vector can be used for the expression and study of the SIRT1 protein in various cell lines and research applications.

Automatically generated - may contain errors

3 protocols using pcdna sirt1

1

Modulating SIRT1 expression in colorectal cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
LOVO and SW480 cells (1 × 105) were seeded onto 6-well plates. Short interfering RNA of SIRT1 (siSIRT1) 5′- CCAAGCAGCUAAGAGUAAUTT-3′ (sense), 5′- AUUACUCUUAGCUGCUUGGTT-3′ (antisense) (Genepharma, China) and pcDNA-SIRT1 (Genepharma, China) were transiently transfected into LOVO and SW480 cells when cells reached 70–80% confluence using Lipofectamine™ 3000 Reagent (Invitrogen, USA). After 48 h transfection, the cells were collected for further experiments.
+ Open protocol
+ Expand
2

Sirt1 Overexpression in Insulin-Resistant Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The insulin-resistant FL62891 and HHL5 cells were seeded at a density of 2×105 cells/mL in 6-well plates. The plasmid of Sirt1 was used for Sirt1 overexpression. Then, the overexpression plasmid of Sirt1 (pcDNA-Sirt1, 500ng/µl, GenePharma, Shanghai, China) and negative control (pcDNA-NC, GenePharma) were incubated in Opti-MEM (Invitrogen, Carlsbad, USA) using LipofectamineTM 2000 (Invitrogen, Carlsbad, USA) according to the manufacturer’s protocol. The inhibitor NT157 of IRS1 (3 μM, Beijing Bio Lebo Technology Co., Ltd, Beijing, China) was added in FL62891 and HHL5 cells.15 (link)
+ Open protocol
+ Expand
3

Regulation of Breast Cancer by miR-22 and SIRT1

Check if the same lab product or an alternative is used in the 5 most similar protocols
miR-22 mimics (miR-22), miR-22 inhibitor (anti-miR-22), scrambled negative control miRNA (miR-NC), siRNA specific targeting sirt1 (si-sirt1), scrambled negative control siRNA (si-NC), and plasmid encoding sirt1 (pcDNA-sirt1) were all synthesized by GenePharma Co. Ltd. (Shanghai, China). Breast cancer cells (1  ×  105) were plated into 6-well plates and cultured in medium without antibiotics for approximately 24 h prior to transfection. The next day, cells were transiently transfected with miRNAs, siRNAs or plasmids using Lipofectamine 2000 (Invitrogen). Cells were collected 48 h post-transfection for functional analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!